T1	Value 8 19	18-75 years
T2	Person 3 6	Age
R1	Has_value Arg1:T2 Arg2:T1	
T3	Measurement 54 95	Left ventricular ejection fraction (LVEF)
T4	Value 96 101	â‰¤ 40%
R2	Has_value Arg1:T3 Arg2:T4	
T5	Procedure 103 107	ECHO
R3	AND Arg1:T3 Arg2:T5	
T6	Condition 128 149	chronic heart failure
T7	Measurement 151 155	NYHA
T8	Value 156 171	class II or III
R4	Has_value Arg1:T7 Arg2:T8	
R5	AND Arg1:T6 Arg2:T7	
T9	Temporal 178 199	In the past one month
T10	Observation 235 242	history
T11	Condition 244 261	clinical symptoms
T12	Condition 244 252;266 271	clinical signs
T13	Qualifier 277 294	relatively stable
T14	Scope 235 271	history, clinical symptoms and signs
R6	Has_qualifier Arg1:T14 Arg2:T13	
R7	Has_temporal Arg1:T14 Arg2:T9	
T15	Condition 334 355	chronic heart failure
T16	Procedure 321 355	treatment of chronic heart failure
R8	AND Arg1:T16 Arg2:T15	
T17	Observation 378 400	maximum tolerance dose
T18	Observation 363 374	target dose
T19	Temporal 401 417	for over 1 month
T20	Temporal 437 452	in last 1 month
T21	Observation 422 436	unchanged dose
*	OR T18 T17
T22	Scope 363 400	target dose or maximum tolerance dose
R9	Has_temporal Arg1:T22 Arg2:T19	
*	OR T22 T21
T23	Scope 363 452	target dose or maximum tolerance dose for over 1 month ,or unchanged dose in last 1 month
R10	Has_scope Arg1:T16 Arg2:T23	
T24	Post-eligibility 458 504	Understand and sign the informed consent form;
T25	Non-query-able 458 504	Understand and sign the informed consent form;
